Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

CDRH Gets $193.5 Mil. In House Approps/Ag FY 2004 FDA Spending Measure

This article was originally published in The Gray Sheet

Executive Summary

An additional $9 mil. in CDRH funding provided by the House Appropriations/Agriculture Subcommittee chairman's mark of the FY 2004 FDA spending bill moves the agency closer to reaching appropriation levels needed to sustain a device user fee program

You may also be interested in...



AdvaMed Seeking To Lower New Tech Payment Threshold In House Rx Bill

Authorization of $1.6 bil. in additional funding for new tech "add-on" payments in House Medicare reform legislation represents a move by lawmakers to alleviate hospital concerns with the original new technology provisions

AdvaMed Seeking To Lower New Tech Payment Threshold In House Rx Bill

Authorization of $1.6 bil. in additional funding for new tech "add-on" payments in House Medicare reform legislation represents a move by lawmakers to alleviate hospital concerns with the original new technology provisions

McClellan’s “Strong FDA” Is Unfazed By Device Appropriations Shortfall

FDA is assuring medical device execs that the Bush Administration is united in seeking the additional appropriations required by MDUFMA, but cannot guarantee that funding benchmarks will be met by 2004

UsernamePublicRestriction

Register

OM013626

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel